3/25/2025 – Rakovina Therapeutics Unveils Preclinical Data at the AACR - World's Premier Cancer Research Forum

3/12/2025 – Next-Gen Cancer Treatment: Rakovina's AI-Driven ATR Inhibitors Enter Preclinical Testing

2/26/2025 – Rakovina Therapeutics and Variational AI Strengthen Partnership

2/6/2025 – Rakovina Therapeutics Announces Additional Synthesized Compounds in its AI-Driven Cancer Drug Discovery Program

1/30/2025 – Rakovina Therapeutics Announces Listing on Frankfurt Stock Exchange

1/22/2025 – Rakovina Therapeutics Comments on $500 Billion AI Infrastructure Investment and Its Implications for Healthcare Innovation

1/13/2025 – Rakovina Therapeutics Announces Key Milestone in Cancer Drug Innovation in Collaboration with Variational AI

1/6/2025 – Rakovina Therapeutics Announces Receipt of AI-Derived Drug Candidates and Advancement to Preclinical Validation